It was found in this study that HTV MV, in the absence of infection, with different levels of TLR4-targeted mice and treatments could result in different impacts on pro-inflammatory cytokine levels, such as IL-6 and MIP-2, in the BALF and in the systemic circulation. The gene discussed is IL6; the disease is infection.